Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

ARTV

ARTV News

Newswire

20:44

Artiva Biotherapeutics CEO Aslan Fred Sells Shares at $3.25 and $3.38

16:00

Artiva shares jump 12.81% intraday on positive AlloNK safety data and FDA Fast Track designation for refractory RA.

14:01

Artiva:HC Wainwright & Co. maintains Buy, raises PT to $15 from $12.

08:16

Artiva shares surge 10.31% premarket after positive AlloNK trial data and FDA Fast Track designation for RA.

07:33

AlloNK plus anti-CD20 mAb treatment yields complete B-cell depletion in autoimmune patients.

View More

About ARTV

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More